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Protein phosphatase 2A (PP2A) is a prime example of the multisubunit architecture of protein serine/threonine
phosphatases. Until substrate-specific PP2A holoenzymes assemble, a constitutively active, but nonspecific, catalytic C
subunit would constitute a risk to the cell. While it has been assumed that the severe proliferation impairment of yeast
lacking the structural PP2A subunit, TPD3, is due to the unrestricted activity of the C subunit, we recently obtained
evidence for the existence of the C subunit in a low-activity conformation that requires the RRD/PTPA proteins for the
switch into the active conformation. To study whether and how maturation of the C subunit is coupled with
holoenzyme assembly, we analyzed PP2A biogenesis in yeast. Here we show that the generation of the catalytically
active C subunit depends on the physical and functional interaction between RRD2 and the structural subunit, TPD3.
The phenotype of the tpd3D strain is therefore caused by impaired, rather than increased, PP2A activity. TPD3/RRD2-
dependent C subunit maturation is under the surveillance of the PP2A methylesterase, PPE1, which upon malfunction
of PP2A biogenesis, prevents premature generation of the active C subunit and holoenzyme assembly by
counteracting the untimely methylation of the C subunit. We propose a novel model of PP2A biogenesis in which a
tightly controlled activation cascade protects cells from untargeted activity of the free catalytic PP2A subunit.
Citation: Hombauer H, Weismann D, Mudrak I, Stanzel C, Fellner T, et al. (2007) Generation of active protein phosphatase 2A is coupled to holoenzyme assembly. PLoS Biol
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Introduction
An estimated one third of the cellular proteome is
reversibly phosphorylated on speciﬁc serine/threonine resi-
dues, indicating an involvement of phosphorylation in many,
if not all, cellular processes. The rapid reversibility and the
selective functional effects of phosphorylation on substrate
functions contribute to its critical importance in signaling
cascades. The net phosphorylation of any given regulatory site
is determined both by the enzymes catalyzing the phosphor-
ylation reaction—the protein serine/threonine kinases
(PSTKs)—and by the enzymes catalyzing the dephosphoryla-
tion reaction—the protein serine/threonine phosphatases
(PSTPs). The molecular architecture that allows these two
opposing enzyme classes to achieve substrate speciﬁcity has
evolved very differently in each class. This is reﬂected in the
number of genes coding for PSTKs (;430) versus only about
30 genes encoding catalytic subunits of the PSTPs [1]. Most
PSTKs are multidomain, single-chain enzymes containing a
catalytic and a substrate regulatory domain. PSTPs, however,
are multisubunit enzymes in which the catalytic and regu-
latory subunits are encoded by different genes. Thus the
assembly of different combinations of subunits to produce
phosphatase holoenzymes with different substrate speciﬁcities
compensates for the low number of PSTP catalytic subunits.
A prime example of the PSTP multisubunit architecture is
protein phosphatase 2A (PP2A). PP2A in vivo comprises a
large number of heterodimeric and -trimeric complexes, all
of which contain a catalytic C subunit. In the majority of
PP2A holoenzymes, the C subunit is bound to the regulatory
A subunit, which serves as a scaffold for the interaction with
one of several B-type subunits. The B-type subunits are
responsible for the substrate speciﬁcity and intracellular
localization of the PP2A holoenzymes. Four B-type subunit
families have been identiﬁed in mammalian cells, each family
consisting of several highly related isoforms. In theory, more
than 72 heterotrimeric holoenzymes can be assembled from
the large pool of PP2A subunit isoforms [2].
A major determinant of holoenzyme composition in vivo is
the availability of speciﬁc regulatory subunits, which in turn
depends on their spatially and temporally regulated expres-
sion. Whereas some holoenzymes only form in certain
developmental stages, others are present at all times and
constitute ‘‘housekeeping’’ PP2A complexes. Another impor-
tant determinant seems to be the stoichiometric balance of C,
A, and B-type subunits. Down-regulation of the PP2A C or A
subunit by RNA interference (RNAi) in vivo leads to the rapid
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PLoS BIOLOGYdegradation of the non-targeted subunits, suggesting that
PP2A subunits are stabilized in the holoenzyme, but are
instable as monomeric subunits [3,4]. Consequently, native
PP2A isolated from various tissues consists of dimeric and
trimeric complexes, but does not contain the free monomeric
C subunit [5]. How the absolute levels of PP2A subunits and,
therefore, of holoenzymes are adjusted to the cell’s respective
requirements is unknown, but the catalytic PP2A subunit with
its strictly controlled expression levels seems to play a central
role in this regulatory circuit.
Monomeric C subunits isolated from in vivo–assembled
PP2A holoenzymes possess promiscuous and high activity in
vitro [5,6]. Complex formation with the regulatory A and B-
type subunits suppresses nonspeciﬁc C subunit activity, but
increases the substrate afﬁnity, as reﬂected by the decreased
maximum velocity (Vmax) and Km [7]. Tight control of C
subunit levels provides one explanation for how cells prevent
the consequences of having free and unregulated C subunit
[8]. However, it leaves open the question of how the catalytic
activity of the newly translated C subunit (or transiently free
C subunit, if recycling occurs) is kept in check until
holoenzyme assembly can occur. Holoenzyme assembly is
promoted by reversible methylation of the C subunit
carboxyterminal leucine, which increases its afﬁnity for the
A and B-type subunits [9,10]. Deletion of protein phosphatase
methyltransferase 1 (PPM1), encoding the yeast protein phos-
phatase methyltransferase solely responsible for PP2A meth-
ylation, not only negatively affects the interaction between
the yeast C subunit homologs, PPH21 and PPH22, and the
scaffold subunit, TPD3, but also affects the interaction with
the B subunits, CDC55 and RTS1 [9,10]. The recently solved
structures of a heterotrimeric PP2A complex suggest charge
neutralization of the C subunit C-terminal carboxyl group as
a potential cause for the afﬁnity increase by methylation
[11,12]. Although carboxymethylation is required for stable
complex formation of PP2A holoenzymes in vivo [9,10], this
does not seem to be the case in vitro [12], indicating a more
complex role for C subunit methylation in vivo. Interestingly,
deletion of PPM1 also reduces the catalytic activity of C
subunit [13]. The discrepancy between the high catalytic
activity of the free C subunit isolated in vitro from pre-
existing holoenzymes and the decreased catalytic activity of
the C subunit from a ppm1D strain with a hampered
holoenzyme formation suggests that holoenzyme assembly
might be coupled to the generation of the catalytically active
C subunit and that methylation might play an important role
in both processes.
Recently, we obtained experimental evidence for a con-
served mechanism to generate active and speciﬁc C subunit
in vivo [13]. Deletion of rapamycin-resistant deletion 1 and 2
(RRD1 and RRD2), encoding the yeast homologs of the PP2A
phosphatase activator (PTPA), produces a catalytic subunit
with a conformationally relaxed active site, as indicated by its
low catalytic activity towards phospho-serine/phospho-threo-
nine (P-Ser/P-Thr) substrates, an altered substrate speciﬁcity,
and its metal dependence. RRD2 stably interacts with the
PP2A C subunit and, when expressed ectopically in the rrd1D/
rrd2D strain, partially rescues the catalytic activity of the
PP2A C subunit. RRD1, on the other hand, seems to be
required for the generation of active SIT4, a PP2A-related
phosphatase. Our data suggested a mechanism by which cells
may avoid the risk of free and unregulated catalytic
phosphatase subunits, namely the synthesis of a low-activity
form that requires a functional interaction with an activator
protein for full activity. However, this leaves open the
question how the biogenesis of the catalytic subunit is
coupled to the methylation-dependent PP2A holoenzyme
assembly.
Here we present evidence that the scaffolding PP2A
subunit, TPD3, interacts functionally and physically with
RRD/PTPA in the generation of active and speciﬁc PP2A in
vivo. Further, the PP2A methylesterase, PPE1, plays a multi-
faceted role, since deletion of PPE1 in an rrd1D/rrd2D strain
increases holoenzyme assembly with the B-type subunit
CDC55 without generation of the active C subunit, whereas
deletion of PPE1 in a tpd3D strain restores C subunit activity
despite a failure of holoenzyme formation. Considered in
detail, our results support a model in which C subunit
biogenesis and PP2A holoenzyme assembly depend on a series
of interlocking steps that proceed under surveillance of the
PP2A methylesterase PPE1 by keeping in check the untimely
methylation of the C subunit.
Results
Loss of TPD3 Leads to a Decreased Serine/Threonine
Phosphatase Activity and Altered Substrate Specificity of
the PP2A C Subunit
The scaffolding A subunit is a prerequisite for the assembly
of most PP2A holoenzymes. In the absence of the A subunit,
TPD3, yeast proliferate poorly and have defects in tRNA
transcription at high temperatures and in cytokinesis at low
temperatures [14]. This latter phenotype is similar to the one
caused by overexpression of the PP2A catalytic subunit [15].
It has therefore been assumed, that the unrestricted and
untargeted catalytic activity of the C subunit is responsible
for the observed phenotype in the absence of TPD3. Our
recent work indicated, however, that the PP2A C subunit can
exist in a low-activity form that requires the functional
interaction with RRD/PTPA for the switch into an active P-
Ser/P-Thr–speciﬁc enzyme [13]. Thus we asked whether the
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Author Summary
Multisubunit enzymes, such as protein phosphatase 2A, consist of a
catalytic subunit and one of several regulatory subunits that are
responsible for substrate specificity. Whereas this molecular
architecture enables the assembly of a few components into many
different substrate-specific enzymes, it possesses an inherent danger
in the form of the uncomplexed catalytic subunit with its unspecific
phosphatase activity. Until substrate-specific complexes assemble,
the catalytic subunit would constitute a risk to the cell if no control
mechanisms existed. We recently obtained evidence for the
existence of the catalytic subunit in a low-activity conformation
that requires an activator for the switch into the active conforma-
tion. This requirement suggested that the existing model of protein
phosphatase 2A biogenesis was incomplete, because it could not
explain how the activity of the catalytic subunit is kept in check until
it is assembled with the substrate-targeting subunits. In this study,
we provide evidence that the generation of the active catalytic
subunit is coupled with and regulated by holoenzyme assembly. We
propose a novel model of protein phosphatase biogenesis in which
a tightly controlled activation cascade protects cells from the
potential risk of unspecific dephosphorylation events.observed phenotype of the tpd3D strain, a strain impaired in
holoenzyme assembly, is indeed caused by the unrestricted
activity of the free C subunit.
To analyze PP2A activity under these diverse conditions,
we expressed hemagglutinin (HA)-tagged PPH21 or HA-
tagged PPH22 in the wild-type, tpd3D, and rrd1D/rrd2D strains,
and in a cdc55D/rts1D strain, which lacks the known B-type
subunits of yeast. Anti–HA-tag immunoprecipitates were
tested for catalytic activity towards the P-Ser/P-Thr substrate
phosphorylase a (Figures 1A and S1A). Contrary to the
prediction, the catalytic activity of PPH21 or PPH22 from a
strain lacking the TPD3 subunit was decreased to approx-
imately 25% or approximately 18%, respectively, of the wild-
type activity. The extent of the decrease was similar for
substrate concentrations ranging from 1 lM phosphorylase a
to 100 lM, a concentration 20-fold above the reported Km
value for phosphorylase a (at which concentration the
velocity converges to the Vmax of the enzyme) (Figure S2)
[16]. A decreased catalytic activity, however, was not a general
feature of strains lacking PP2A regulatory subunits. Deletion
of the two known B-type subunits in yeast, CDC55 and RTS1,
did not impair C subunit activity towards phosphorylase a. In
addition, we analyzed the catalytic activity of endogenous C
subunit immunoprecipitates from lysates of a wild-type or a
tpd3D strain that did not express ectopically HA-tagged
PPH21 or PPH22 (Figure S3B). The endogenous C subunit
activity was also severely impaired towards phosphorylase a in
the tpd3D strain. Thus, TPD3 seems to fulﬁll functions in
addition to serving as the scaffold for the interaction with B-
type subunits.
The C subunit in the rrd1D/rrd2D strain shows a decreased
P-Ser/P-Thr–speciﬁc activity. Strikingly, however, it gains
high activity towards para-nitrophenyl phosphate (pNPP), a
small-molecule substrate with a bulky phospho-tyrosine–like
group [13] (Figure 1B). Both C subunits, PPH21 as well as
PPH22, displayed several-fold higher activities towards pNPP
in the tpd3D strain than in the wild-type strain (Figures 1B
and S1B). Thus, loss of TPD3 led to the generation of C
subunits with altered catalytic properties, indicating a role
for TPD3 in C subunit biogenesis.
Decreased Catalytic Activity Is Intrinsic to the C Subunit
The decreased C subunit activity and altered substrate
speciﬁcity in the tpd3D strain were reminiscent of the
hampered PP2A activity in a strain lacking RRD1 and RRD2
[13]. RRD2 is known to form stable interactions with the yeast
C subunits and to be signiﬁcantly more active in vivo on the
PP2A catalytic subunit than RRD1 is. We asked whether the
interaction of the C subunit with RRD2 was affected by
deletion of TPD3. Anti–HA-tag immunoprecipitates from
lysates of the wild-type, tpd3D, rrd1D/rrd2D, cdc55D/rts1D, and
ppm1D strains were analyzed for the presence of RRD2
(Figure 2A). The interaction of HA-tagged PPH21 with RRD2
was only slightly reduced in the tpd3D strain (64% 6 26% of
wild-type strain level, n ¼ 10), but the levels of associated
TAP42, a highly conserved and essential subunit of the PP2A
family, increased several-fold, as has been shown by others
[17]. Competency for TAP42 binding indicated that deletion
of TPD3 did not lead to formation of denatured C subunit.
The increased levels of TAP42:C subunit complexes in a tpd3D
strain have been attributed to the lack of PP2A heterotrimers,
which may promote the dissociation of the TAP42:C subunit
complex by dephosphorylation of TAP42 [18]. However, in
contrast to the tpd3D strain, the level of TAP42:C subunit
complexes remained unchanged in the cdc55D/rts1D strain,
indicating that the presence or absence of heterotrimeric
PP2A does not alter the stability of the TAP42:C subunit
complexes.
Genetic evidence indicates an inhibitory role for TAP42 on
phosphatase activity [19]. To exclude the possibility that the
decreased catalytic activity and altered substrate speciﬁcity of
the C subunit isolated from the tpd3D strain is simply due to
formation of the TAP42:C subunit complex or binding of an
unknown inhibitor, we measured the catalytic activity of
immunoprecipitated HA-tagged PPH21 that was stripped of
associated proteins, including TAP42, at alkaline pH (Figure
Figure 1. Loss of TPD3 Leads to a Decreased Serine/Threonine
Phosphatase Activity and Altered Substrate Specificity of the PP2A C
Subunit
The catalytic activity of anti-HA immunoprecipitates from lysates of wild-
type (wt), tpd3D, rrd1D/rrd2D, and cdc55D/rts1D cells expressing HA-
tagged PPH21 was analyzed by phosphatase assays towards (A)
phosphorylase a (n ¼ 12, mean 6 standard deviation) or (B) para-
nitrophenyl phosphate, pNPP (n ¼ 4, mean 6 standard deviation). An
additional background measurement (corresponding to the wild-type
strain containing the empty vector pYX142 was included for every assay
(A and B) and subtracted from each measuring point (see Materials and
Methods for more details).
doi:10.1371/journal.pbio.0050155.g001
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we analyzed pH-treated lysates from a wild-type or tpd3D
strain by sucrose gradient sedimentation/centrifugation
(Figure S4). The pH treatment shifted HA-tagged PPH21 to
lower molecular weight fractions, indicating dissociation of C
subunit complexes and the presence of monomeric C
subunits. Compared with the wild-type strain, the ‘‘free’’ C
subunit from the tpd3D strain was still impaired in catalytic
activity (Figure 2C), indicating that the defect is intrinsic to
the C subunit and not caused by the increased binding of
T A P 4 2o ra n yo t h e ri n h i b i t or. C subunit activity was
decreased even at high substrate concentrations (Figure S5),
conﬁrming the results obtained with the complexed C
subunit and indicating a defect in the catalytic mechanism.
In summary, loss of TPD3 led to alterations of C subunit
activity and speciﬁcity, which are most probably due to
changes at the active site that are reminiscent of the
alterations observed in the absence of RRD1/RRD2.
RRD2 Interacts Physically and Functionally with TPD3
The similarity in the defect of the C subunit in the tpd3D
and rrd1D/rrd2D strains raised the possibility of a physical and/
or functional interaction between RRD2 and TPD3:PPH21
dimers. We therefore tested whether RRD2, TPD3, and
PPH21 can form a trimeric complex in a wild-type strain, a
possibility that has been suggested recently, but not proven
[20]. First we analyzed myc-tagged RRD2 immunoprecipitates
from lysates of the wild-type strain co-expressing HA-tagged
PPH21, for associated PP2A subunits (Figure 3A) and
compared it with the composition of HA-PPH21 immuno-
precipitates from lysates of the same strain. The analysis
revealed that approximately 5%–10% of PPH21 was associ-
ated with RRD2 in a wild-type cell. Moreover, the RRD2-
bound PPH21 was unmethylated, indicating that methylation
probably was not a requirement for complex formation with
RRD2. This was in agreement with the association between
PPH21 and RRD2 in the ppm1D strain (Figure 2A). RRD2 also
associated with TPD3, but not with the regulatory subunits
TAP42, CDC55, RTS1, and PPE1 (unpublished data). The lack
of interaction with TAP42 was in contrast to the recent
identiﬁcation of TAP42:RRD1 and TAP42:RRD2 complexes
and might be due to differences in experimental conditions
and/or the strain background [20].
To test whether RRD2, TPD3, and PPH21 co-exist in the
Figure 2. Decreased Catalytic Activity Is Intrinsic to the C Subunit
(A) Anti–HA-tag immunoprecipitates from lysates of wild-type (wt) cells
containing an empty vector (control) or wild-type, tpd3D, rrd1D/rrd2D,
cdc55D/rts1D, and ppm1D cells expressing HA-tagged PPH21 were
analyzed by SDS-PAGE and immunoblotting. The blots were sequentially
incubated with specific antibodies against HA-tag, RRD2, and TAP42.
Lanes 4–6 were not adjacent on the original blot.
(B) Monomeric C subunits from the wild-type and the tpd3D strains were
obtained by immunoprecipitation from lysates in which protein
complexes had been disrupted by a basic pH shift, followed by
neutralization (monomeric), or from control untreated lysates (com-
plexed) (see Materials and Methods for details). The HA-PPH21
immunoprecipitates were analyzed by SDS-PAGE and immunoblotting.
(C) An aliquot of the monomeric HA-PPH21 immunoprecipitates was
tested by phosphatase assays towards phosphorylase a (n ¼ 3).
doi:10.1371/journal.pbio.0050155.g002
Figure 3. RRD2 Interacts Physically and Functionally with TPD3
(A) HA-PPH21 or myc-RRD2 immunoprecipitates (IP) from lysates of wild-
type (wt) cells co-expressing HA-PPH21 and myc-RRD2 were analyzed by
SDS-PAGE and immunoblotting. The blots were sequentially incubated
with anti-methyl PP2A/PPH21 (2A10), rabbit polyclonal anti-TPD3, anti-
RRD2, anti-TAP42, and anti-PPH21 antibody. endog., endogenous.
(B) Anti–Myc-tag immunoprecipitates from lysates of wild-type cells co-
expressing myc-RRD2 and HA-PPH21 were eluted by peptide competi-
tion and re-immunoprecipitated via HA-PPH21 (see Materials and
Methods for details). ‘‘Control’’ indicates a wild-type strain containing
both empty vectors. The re-immunoprecipitates were analyzed by SDS-
PAGE and immunoblotting using specific antibodies.
(C) rrd1D/rrd2D and rrd1D/rrd2D/tpd3D cells containing the plasmid
PYES2[myc-TPD3] were grown to log phase in complete dropout
medium. Growth of the double and triple mutant was compared by
spotting equal amounts of 10-fold serially diluted cells onto synthetic
complete (SC) medium plates 6 1 g/l 5-fluoroorotic acid (5-FOA). The
plates were incubated for 2 d (SC) or 5 d (SCþ5-FOA) at 30 8C. Screening
on 5-FOA selects for the loss of the URA3 plasmid PYES2[myc-TPD3] and
indicates dependency of viability on TPD3.
doi:10.1371/journal.pbio.0050155.g003
PLoS Biology | www.plosbiology.org June 2007 | Volume 5 | Issue 6 | e155 1358
PP2A Activity and Holoenzyme Assemblysame complex, we immunoprecipitated myc-tagged RRD2
from lysates of a wild-type strain co-expressing HA-tagged
PPH21, eluted the RRD2 complexes with the myc-epitope
peptide, and re-immunoprecipitated the complexes via HA-
tagged PPH21 (Figure 3B). Analysis of the HA-PPH21
immunoprecipitates with antibodies to the A subunit,
TPD3, revealed that these proteins indeed are in the same
multimeric complex. These ﬁndings are consistent with TPD3
and the RRD proteins playing a common role in C subunit
biogenesis. To further test the functional interaction between
these proteins, we deleted TPD3 and both RRD genes and
examined the strain viability by a proliferation assay. In line
with our hypothesis, deletion of TPD3 and both RRD genes
was synthetically lethal (Figure 3C), providing further
evidence for the essential functional and/or physical inter-
action of these proteins.
Strains Impaired in C Subunit Biogenesis Display
Decreased C Subunit Methylation and Increased PPE1
Binding
The 36% decreased interaction between RRD2 and the C
subunit (Figure 2A) cannot explain the 75% decreased
catalytic activity towards phosphorylase a in a tpd3D strain
(Figure 1A), because deletion of RRD2 reduces catalytic
activity towards phosphorylase a and other P-Ser/P-Thr
substrates only by about 45%–50% [13]. We therefore
investigated whether the reversible methylation of the C
subunit, which is required for stable holoenzyme formation
[9,10], but probably also for the activation of PP2A activity
[13], was also altered in the tpd3D strain (Figure 4A). Anti–
HA-tag immunoprecipitates from lysates of the wild-type,
tpd3D, rrd1D/rrd2D, and ppm1D strains were analyzed with the
methylation-speciﬁc monoclonal antibody 2A10. No C sub-
unit methylation was detected in the strain deleted for PPM1
(Figure 4A, lane 5), proving the speciﬁcity of the 2A10
antibody. Surprisingly, PPH21 was almost completely un-
methylated in the tpd3D strain and markedly hypomethylated
in the rrd1D/rrd2D strain compared to the wild-type strain,
suggesting that in the absence of TPD3 or RRD/PTPA, the
catalytically impaired C subunit became either a preferred
substrate for PPE1 or an unfavored substrate for PPM1.
To identify the potential cause for the decreased methyl-
ation levels in these strains, we analyzed HA-tagged PPH21
immunoprecipitates for associated PPE1 or PPM1. The yeast
methyltransferase, PPM1, did not form stable complexes with
the C subunit in either the wild-type or the deletion strains,
suggesting that methylation occurs during a transient
interaction between substrate and enzyme (unpublished
data). However, deletion of either TPD3 or RRD1/RRD2
caused an increase in the abundance of a PPE1:PPH21
complex (Figure 4A), suggesting that the reduced methylation
levels of PPH21 resulted from increased PPE1 binding (Figure
4A, lower panel). The complex formation between PPE1 and
PPH21 in the ppm1D strain, however, also showed that
methylation was not a prerequisite for the interaction of
PPE1 with the C subunit. In summary, these data indicated
that the PPE1:C subunit complex formation represents an
early step in PP2A biogenesis and that interruption of the
cascade causes accumulation of these complexes.
An increase in the abundance of PPE1:PPH21 complexes
and demethylation of the C subunit correlated with an
impaired catalytic activity in the tpd3D or rrd1D/rrd2D strains.
We therefore asked whether overexpression of PPE1 in a
wild-type strain would also negatively affect C subunit activity
(Figure 4B and 4C). Loss of C subunit methylation by high-
level overexpression of PPE1 correlated with a large increase
in the amount of PPE1:PPH21 complexes, a profound
reduction in the binding of PPH21 to RRD2 and TPD3
(Figure 4B), and a severely reduced PPH21 phosphatase
activity towards phosphorylase a (Figure 4C). These data
suggest that the impaired catalytic activity of the C subunit in
a tpd3D strain was due to the increased PPE1 binding and
demethylation of the C subunit, which prevented the next
critical step in C subunit biogenesis.
Deletion of PPE1 Restores C Subunit Activity in the tpd3D,
but Not in the rrd1D/rrd2D Strain
If demethylation blocks C subunit maturation, then
deletion of the PPE1 gene in a tpd3D strain might allow the
biogenesis to proceed and restore the impaired catalytic
activity of the C subunit. Deletion of PPE1 in the absence of
RRD1/RRD2, the essential factors for the generation of active
PP2A [13], however, should, if anything, worsen the defective
C subunit biogenesis. Thus, we analyzed the activity and
complex composition of HA-PPH21 from a series of deletion
strains (Figure 5A and 5B). As before, tpd3D and rrd1D/rrd2D
strains had marked hypomethylation of PPH21. As predicted,
Figure 4. Strains Impaired in C Subunit Biogenesis Display Decreased C
Subunit Methylation and Increased PPE1 Binding
(A) Anti–HA-tag immunoprecipitates (IP) from lysates of wild-type (wt),
tpd3D, rrd1D/rrd2D, and ppm1D cells expressing HA-tagged PPH21 were
analyzed by SDS-PAGE and immunoblotting. C subunit methylation and
the presence of PPE1 were analyzed using specific antibodies.
(B and C) HA-PPH21 immunoprecipitates from lysates of wild-type cells
expressing HA-tagged PPH21 together with myc-tagged methylesterase
(myc-PPE1) (overnight induction under the control of the GAL1
promoter), or containing an empty pYES2 vector (vector), were analyzed
by SDS-PAGE/immunoblotting (B) and by phosphatase assays (C)
towards phosphorylase a (n ¼ 3). The blots were sequentially incubated
with anti-methyl PP2A, anti-RRD2, rabbit polyclonal anti-TPD3, anti-PPE1,
and anti-HA antibodies. endog., endogenous.
Lanes 4 and 5 (A) and lanes 2 and 3 (B) were not adjacent on the original
blot.
doi:10.1371/journal.pbio.0050155.g004
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these strains, but even increased it, indicating that PPE1 is
responsible for the reduced amounts of methylated C
subunits in these strains (Figure 5A). Importantly, PPE1
deletion affected C subunit biogenesis in distinctly different
ways in the tpd3D versus the rrd1D/rrd2D strain. In the tpd3D
strain, PPE1 deletion restored C subunit activity (n ¼ 7, p ,
0.001) towards phosphorylase a almost to the level of the wild-
type strain (Figure 5B). Thus, TPD3 is not required for
formation of the catalytically active C subunit.
In contrast, the RRD1/RRD2 proteins were required for the
restoration of phosphatase activity: in the rrd1D/rrd2D strain,
the impaired C subunit activity not only could not be rescued
by PPE1 deletion, but was further reduced (n ¼ 7, p , 0.05)
(Figure 5B). The same was true for the activity towards cdc2-
phosphorylated histone H1, a substrate known to be
speciﬁcally dephosphorylated by heterotrimeric complexes
containing the B subunit [21] (unpublished data). The
restoration of C subunit methylation in this strain, however,
led to a huge increase in formation of inactive holoenzymes
with TPD3 and CDC55. Of note, in these inactive complexes,
a subset of CDC55 migrated with decreased electrophoretic
mobility (Figure 5A). Treatment with k-phosphatase shifted
the slower form to the faster migrating form of CDC55,
indicating that the altered electrophoretic mobility of CDC55
was probably due to phosphorylation (unpublished data).
Interestingly, our previous analysis had revealed that in the
absence of RRD1/RRD2, the level of a post-translationally
modiﬁed form of CDC55 is also increased [13], raising the
intriguing possibility that RRD/PTPA function regulates the
modiﬁcation/phosphorylation state of CDC55 and probably
also of the other B-type subunit, RTS1 (unpublished data).
The exacerbation of the impaired C subunit activity in the
rrd1D/rrd2D strain upon deletion of PPE1 indicated a func-
tional and/or physical interaction between these proteins.
Since we did not detect a physical interaction between PPE1
and RRD1 or RRD2 (unpublished data), the data are
consistent with RRD1/RRD2 and PPE1 being in the same
functional pathway without being in a complex.
The impaired C subunit activity in the tpd3D strain seems
to be responsible for the severe proliferation phenotype of
this strain. If the impaired activity is indeed the cause for the
phenotype, then reactivation of C subunit activity upon PPE1
deletion might alleviate the severity of the phenotype.
Therefore, we measured the proliferation of these strains at
different temperatures (Figure 5C). However, the tpd3D/ppe1D
strain with its restored PP2A activity grew only slightly better
at all tested temperatures than the tpd3D strain. We suspect
that this minor improvement is due to the lack of properly
targeted and regulated PP2A holoenzymes. In the rrd1D/rrd2D
strain, the proliferation phenotype was aggravated upon
PPE1 deletion, despite the increase in trimeric holoenzymes,
most likely due to the severe defect in catalytic activity.
C Subunit Methylation Is Required for the Restoration of C
Subunit Activity in the tpd3D/ppe1D Strain
The increase of C subunit methylation in the tpd3D/ppe1D
strain correlated with a restoration of the impaired catalytic
activity, indicating a potential requirement for methylation
in the C subunit activation process, a role to which our
previous data had already pointed [13]. To test this
hypothesis, we deleted the PPM1 gene in the tpd3D/ppe1D
strain and analyzed the methylation state and catalytic
activity towards phosphorylase a in this strain (Figure 6A
and 6B). Loss of C subunit methylation in this strain caused a
huge decrease in catalytic activity (n ¼ 7, p , 0.001) (Figure
6B), underscoring the importance of methylation for C
subunit activation. Thus, PPE1 probably delays progression
of the biogenesis cascade in the tpd3D strain by keeping the C
subunit in an unmethylated state.
Figure 5. Deletion of PPE1 Restores C Subunit Catalytic Activity in the
tpd3D, but Not in the rrd1D/rrd2D Strain
(A) HA-tagged PPH21 was immunoprecipitated from lysates of wild-type
(wt), ppe1D, rrd1D/rrd2D, rrd1D/rrd2D/ppe1D, tpd3D, and tpd3D/ppe1D
cells. The immunoprecipitates were separated by 10% SDS-PAGE and
analyzed by immunoblotting with anti-HA, anti-methyl PP2A, mono-
clonal anti-TPD3, anti-CDC55, anti-RRD2, and anti-PPE1 antibodies.
(B) Aliquots of the anti–HA-tag immunoprecipitates used in (A) were
assayed for phosphatase activity using phosphorylase a as substrate (n¼
7).
(C) Logarithmically growing cultures of wild-type, ppe1D, rrd1D/rrd2D,
rrd1D/rrd2D/ppe1D, tpd3D, and tpd3D/ppe1D were 10-fold serially diluted
in YPD liquid medium, spotted on YPD plates, and incubated at 16 8C for
5d ,o ra t3 08Co r3 78C for 3 d.
doi:10.1371/journal.pbio.0050155.g005
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Here we identify a critically important functional and
physical interaction between RRD2 and the structural
subunit TPD3 in C subunit maturation. RRD2/TPD3 interacts
preferentially with the demethylated and inactive form of the
C subunit by targeting the PPH21:PPE1 complex. PPE1,
therefore, may fulﬁll a surveillance function of TPD3/RRD2-
dependent C subunit maturation by preventing untimely C
subunit methylation and hence the premature generation of
active C subunit and holoenzyme assembly (see model, Figure
7).
The catalytic subunit of a multisubunit enzyme like PP2A
achieves substrate speciﬁcity by complex formation with
regulatory subunits [22]. The combinatorial assembly of
holoenzymes from a large pool of distinct regulatory subunits
generates a great number of different substrate-speciﬁc
complexes and explains how a single catalytic subunit is able
to perform so many functions. Inherent to the multisubunit
enzyme architecture, however, is the problem of how the
promiscuous catalytic activity of the free catalytic subunit is
kept in check until holoenzymes form. Recently, we obtained
experimental evidence for a potential control mechanism,
which involves synthesis of the PP2A catalytic subunit in a
low-activity form that requires the functional interaction
with RRD/PTPA for the switch into an active and speciﬁc
enzyme [13]. Here we show that the scaffolding subunit TPD3
functionally and physically interacts with RRD2 in the
generation of the active and speciﬁc PP2A C subunit,
indicating that C subunit maturation is coupled and
coordinated with holoenzyme assembly.
Biochemical analyses indicated that in vitro, binding of the
A subunit to the C subunit decreases the phosphatase
catalytic rate and increases substrate speciﬁcity [7]. However,
the effects of PP2A A subunit binding on C subunit catalytic
properties were determined with C subunits isolated from
catalytically active PP2A holoenzymes, because the free C
subunit does not seem to exist in substantial amounts in vivo.
On the basis of these in vitro observations, it has been
assumed that loss of the A subunit in vivo will leave behind
the monomeric C subunit with high and promiscuous
catalytic activity. The data presented here demonstrate that
this assumption is incorrect. Our analysis of the tpd3D strain
indicates that the A subunit provides an additional function
besides narrowing the substrate speciﬁcity of an otherwise
promiscuous C subunit. As evidenced by genetic and physical
interactions, the A subunit also cooperates with RRD/PTPA in
the generation of the active C subunit in vivo.
What is the regulatory role of TPD3 in this process? TPD3
formed a multimeric complex with RRD2 and PP2A C
subunits. This complex appears to be essential for PP2A
biogenesis and differs in several aspects from B-type subunit-
containing holoenzymes. In contrast to B-type subunits,
RRD2 interacted preferentially with the unmethylated C
subunit, suggesting methylation state-dependent regulation
of RRD2:C subunit interaction. We found, consistent with this
hypothesis, that deletion of PPE1 (as well as PPM1 over-
expression; unpublished data) decreased the levels of
RRD2:TPD3:C subunit complexes. RRD2:TPD3:PPH21 hol-
Figure 6. C Subunit Methylation Is Required for the Restoration of C
Subunit Activity in the tpd3Dppe1D Strain
HA-tagged PPH21 was immunoprecipitated from lysates of wild-type
(wt), tpd3D, tpd3D/ppe1D, and tpd3D/ppe1D/ppm1D cells. The immuno-
precipitates (IP) were (A) analyzed by 10% SDS-PAGE/immunoblotting
and (B) assayed for phosphatase activity using phosphorylase a as
substrate (n ¼ 7).
doi:10.1371/journal.pbio.0050155.g006
Figure 7. Model: RRD/PTPA-Dependent Generation of Active PP2A C
Subunit Is Coupled to Holoenzyme Assembly and Regulated by Methyl-
Esterase/Transferase Enzymes
doi:10.1371/journal.pbio.0050155.g007
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complex whose stability is regulated in an opposite manner to
other PP2A holoenzymes, namely by demethylation rather
than methylation. The binding preference of RRD2 for the
demethylated C subunit suggests an important role for PPE1,
the enzyme catalyzing the demethylation, as well as for the
carboxyl terminus itself in the interaction with RRD2. In
accordance with our prediction, a C subunit mutant lacking
the carboxy-terminal nine amino acids including the site of
methylation did not bind RRD2, and the monoclonal
antibody 7A6 directed to the C subunit carboxyl terminus
did not co-precipitate RRD2 (unpublished data), indicating
that the C subunit carboxyl terminus seems to be essential for
the interaction (directly or indirectly) with RRD2. The
impaired catalytic activity of the deletion mutant towards
phosphorylase a (unpublished data) provided further evi-
dence for the functional cooperation between the C subunit
carboxyl terminus and RRD2.
So far, no obvious phenotype has been identiﬁed following
deletion of PPE1 in yeast [10], raising questions about PPE19s
role and importance in vivo as the opposing enzyme of the
PP2A methyltransferase, PPM1. Whereas PPM1 function (C
subunit methylation) is a prerequisite for stable complex
formation with B-type subunits [9,10], the PPE1 function in
the regulation of trimeric PP2A holoenzymes remained
obscure because conﬂicting data exist on its ability to
demethylate the C subunit once it is bound to B-type
subunits [23,24]. Thus, it is currently thought that PPE1
regulates PP2A holoenzyme assembly with B-type subunits by
shifting the equilibrium between the demethylated and the
methylated AC core dimer. Our data indicate a role for PPE1
earlier in the biogenesis of PP2A, namely in the regulation of
c o m p l e xa s s e m b l yw i t hR R D 2r a t h e rt h a nw i t hB - t y p e
subunits. PPE1 appears to be required for stable complex
formation between the C subunit and TPD3:RRD2, and
counteracts the premature methylation of the C subunit that
has not yet been activated by TPD3:RRD/PTPA. Defects in C
subunit biogenesis, for example by deletion of either the
TPD3 or RRD genes, caused the accumulation of complexes
of PPE1 and the C subunit in its low-activity conformation.
Thus, PPE1 seems to constitute a surveillance mechanism that
prevents the premature generation of the active C subunit in
the absence of the scaffolding subunit TPD3, the major
constituent of PP2A holoenzymes, or premature holoenzyme
assembly in the absence of the essential activator RRD/PTPA.
PPE1 seems to achieve this function in two ways, by
competing with RRD2 for the binding to the C subunit and,
more importantly, by keeping the C subunit in its demethy-
lated state and thereby preventing untimely methylation that
would otherwise complete the C subunit activation and
promote complex formation with B-type subunits. In line
with this prediction, deletion of PPE1 in a tpd3D strain
overcame the PPE1-dependent block of C subunit maturation
despite the inability for holoenzyme formation, and deletion
of PPE1 in the rrd1D/rrd2D strain increased dramatically the
levels of trimeric holoenzymes with CDC55 despite the fact
that the C subunit was in its inactive conformation.
How do defects in C subunit biogenesis lead to the
increased interaction between PPE1 and the C subunit? At
the moment, our data do not allow us to distinguish between
several potential scenarios of PPE1 function. In the ﬁrst
scenario, PPE1 constitutes one of the ﬁrst steps of C subunit
biogenesis, interacting with the newly synthesized C subunit in
its low-activity conformation. Interruptions of the biogenesis
cascade would then cause the accumulation of complexes
from earlier steps because dissociation of these complexes is
interlocked with formation of the subsequent complex, e.g.,
the TPD3:RRD2 complex. In the second scenario, PPE1 plays a
more active role by interacting with and demethylating C
subunits that have not yet been activated by RRD/PTPA. PPE1
could achieve this by a substrate preference for any C subunit
in its low-activity conformation, including those that are
newly synthesized and inactive. Our results from PPE1
overexpression experiments (but also the ﬁnding of increased
PPE1 binding levels in the tpd3D and rrd1D/rrd2D strains) are
also consistent with a third mechanism in which PPE1 targets
the catalytically active C subunit, demethylates it, and through
its binding to catalytic site residues, converts the C subunit
into the low-activity conformation, which subsequently
requires RRD/PTPA as well as C subunit methylation for
recycling in the biogenesis cascade.
This biogenesis mechanism appears to function in mam-
mals as well as yeast. Consistent with an afﬁnity of PPE1 for
the inactive C subunit, we were able to identify and isolate the
mammalian PPE1 ortholog, PME1, by its increased inter-
action with catalytically defective C subunit mutants [25], and
PME-1 was recently co-puriﬁed with inactive PP2A [24].
Interestingly, several of the human C subunit active-site
mutant proteins also bind increased levels of PTPA (the
mammalian ortholog of RRD2) as well as a4/TAP42 [13],
suggesting a binding preference of both PTPA and a4/TAP42
for the inactive conformation of the C subunit. The increased
binding of these molecules to C subunit mutants that are
unable to fold into the catalytically active conformation and
complete the biogenesis suggests that they might play key
roles in the early steps of C subunit biogenesis.
TAP42 is an essential protein [17] known to interact with
the catalytic subunits of the PP2A family of phosphatases,
including PPH21, PPH22, SIT4, and PPH3 [26]. A recent study
identiﬁed RRD1 and RRD2 as part of the TAP42:phosphatase
complexes [20] in the W303 strain, and conﬁrmed earlier
ﬁndings that RRD/PTPA proteins are required for phospha-
tase activity [13,27]. In addition, these authors detected a
complex between the RRD proteins and TPD3, but the
signiﬁcance of this complex remained unclear. Our results
now identify the functional and physical interaction between
RRD2 and TPD3 in C subunit biogenesis. In contrast to their
ﬁndings, we were unable to detect signiﬁcant complex
formation between RRD2 and TAP42 in the BY strain. Thus,
the observed differences may be due to the different genetic
backgrounds of the W303 and BY strains. It will be interesting
to test whether and how the differences in TAP42:RRD
complexes affect PP2A biogenesis in these strains.
By what mechanism might RRD/PTPA regulate C subunit
biogenesis? We showed recently that loss of RRD proteins
results in the generation of PP2A and SIT4 catalytic subunits
with impaired catalytic activity, indicating alteration of the
active site. Thus, we hypothesized that RRD/PTPA might play
a role in the generation of the native conformation of the
PP2A and SIT4 active sites. In line with our assumption,
preliminary evidence has been provided for a potential
peptidyl-prolyl cis/trans isomerase (PPIase) activity of RRD/
PTPA [28] that is stimulated by ATP/Mg
2þand, which could be
responsible for switching the C subunit into the active
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further provided by the recent structure determination of
RRD/PTPA in complex with a proline-containing PPIase
peptide substrate [29]. No ATP binding site, however, could
be identiﬁed in the RRD/PTPA structure [29,30]. Interest-
ingly, SSB2, a ribosome-associated chaperone that possesses
ATPase activity and plays a role in the folding of newly
synthesized proteins has been found just recently in a
complex with TPD3 [31]. It is tempting to speculate that the
energy necessary for the PTPA-catalyzed conformational
change in the C subunit might be provided by ATP hydrolysis
through the TPD3-bound SSB2. It would also provide a
potential explanation for our ﬁnding of the functional and
physical interaction between RRD/PTPA and TPD3. Chao et
al. [32], however, identiﬁed an ATP binding pocket in their
structure of PTPA and showed that PTPA and the PP2A A-C
dimer together constitute a composite ATPase, whose activity
is required for the transient change of PP2A into a
phosphotyrosine (P-Tyr)-speciﬁc phosphatase, at least in
vitro. How the loss of this transient P-Tyr–speciﬁc activity
would lead to the huge decrease of the P-Ser/P-Thr–speciﬁc
activity of trimeric PP2A holoenzymes that is observed in the
rrd1D/rrd2D strain [13], or now in the rrd1D/rrd2D/ppe1D strain,
is unclear. The requirement for an activator protein,
however, is not unique to the PP2A family of phosphatases.
Inhibitor-2 (I-2), a highly conserved protein, interacts with
the catalytic subunit of protein phosphatase 1 (PP1) and
inhibits its catalytic activity in vitro [33]. Deletion of GLC8,
encoding the yeast I-2 ortholog, however, leads to a reduction
and not to an increase of GLC7 catalytic activity, as would
have been expected for the loss of an inhibitor [34]. The
catalytically inactive PP1 in complex with I-2 is activated
upon phosphorylation of I-2, which probably induces a
conformational change in PP1, suggesting a function of
inhibitor-2 as a PP1 chaperone [35,36]. Whether the I-2
chaperone function, and thus the generation of active PP1, is
also coupled to and coordinated with PP1 holoenzyme
assembly is currently unknown, but—given our present
results—this is a likely possibility.
Deletion of RRD/PTPA affected the post-translational
modiﬁcation state of the yeast B-type subunits CDC55 [13]
and RTS1 (unpublished data), suggesting the intriguing
possibility that phosphorylated B-type subunits are substrates
of RRD/PTPA complexes in vivo. RRD/PTPA may represent a
unique species of PP2A regulatory subunits, with a very
restricted number of (potentially even P-Tyr) phosphorylated
substrates. In this way, the generation of the active C subunit
would be tightly coupled to the formation of substrate-
speciﬁc holoenzymes. Cells could avoid potential damage
from the highly active but untargeted C subunit by coupling
the RRD/PTPA-dependent maturation process to the inter-
action of the C subunit with the scaffolding subunit TPD3,
which in turn constitutes a prerequisite for holoenzyme
assembly with B-type subunits (model, Figure 7). The order of
events seems to be under the surveillance of the PP2A
methylesterase that preferentially binds to the C subunit in its
low-activity conformation, consistent with PPE19s increased
afﬁnity for inactive C subunit mutants. Demethylation of the
C subunit by PPE1 is required for the efﬁcient interaction
with RRD2, and at the same time, demethylation prevents
interaction with B-type subunits. TPD3 and RRD2 are both
required for the release of PPE1 and the generation of the
active and speciﬁc C subunit. The RRD2-dependent activa-
tion of the phosphatase catalytic activity is coupled to the
assembly with B-type subunits by targeting the RRD2:TPD3:C
subunit complexes to their potential substrates, phosphory-
lated B-type subunits. The process is completed by C subunit
methylation destabilizing the interaction with RRD2 and, at
the same time, stabilizing the one with B-type subunits. This
model provides an explanation for how cells deal with the
inherent danger of the multisubunit enzyme architecture,
namely the untargeted and unrestricted catalytic activity of
the free C subunit.
Materials and Methods
Yeast strains, gene disruption, and growth media. Saccharomyces
cerevisiae strains used in this study are listed in Table 1. The double-
deletion strains cdc55D/rts1D and tpd3D/ppe1D were generated by PCR-
based gene targeting [37] from the single-deletion strains rts1D and
tpd3D, respectively. The rrdD/rrd2D/ppe1D strain was obtained by
mating the strains rrd1D/rrd2D (MATa) and ppe1D (MATa, EUROpean
Saccharomyces Cerevisiae ARchive for Functional analysis [Euroscarf],
http://web.uni-frankfurt.de/fb15/mikro/euroscarf/index.html), fol-
lowed by sporulation and tetrad dissection. The tpd3D/ppe1/Dppm1D
strain was obtained in the same way, by mating the strains tpd3D/
ppe1D (MATa) and ppm1D (MATa; Euroscarf). After phenotypic
analysis, gene deletions were conﬁrmed by PCR and by immunoblot-
ting analysis of yeast lysates with speciﬁc antibodies.
The strains were grown at 30 8C in rich medium (YPD) or complete
minimal (CM) dropout medium supplemented with 2% glucose or
2% galactose and 0.1% rafﬁnose.
Plasmids. Plasmids used for this study are summarized in Table 2.
Detailed cloning strategies and information of the individual
constructs can be obtained upon request.
Synthetic lethality analysis. Analysis of 74 tetrads obtained by
mating rrd1D/rrd2D (MATa [13]) with the tpd3D (MATa; Euroscarf)
strain revealed the absence of any viable rrd1D/rrd2D/tpd3D triple-
deletion mutant. To corroborate these data, the heterozygous diploid
strain was transformed with the plasmid pYES2[myc-TPD3] (2 lm,
URA3)andsporulated.Thesporesweredissected,analyzedphenotypi-
cally for the presence of resistance and auxotrophic markers (Kan
R,
His
þ, and Ura
þ), and tested for protein expression by immunoblotting.
The Ura
þ rrd1D/rrd2D/tpd3D mutants were spotted on synthetic
complete (SC) medium plates 6 1 g/l 5-ﬂuoroorotic acid (5-FOA).
Yeast cell extracts, immunoprecipitation, and immunoblotting.
The preparation of whole-cell yeast extracts was carried out as
previously described [13]. HA- or myc-tagged proteins were immu-
noprecipitated by using anti-HA (12CA5) or anti-myc (4A6; Upstate,
http://www.upstate.com) antibodies cross-linked to BSA-coated pro-
tein A sepharose beads (Pharmacia Biotech [GE Healthcare], http://
www.gehealthcare.com/usen/index.html) as described previously [38].
To avoid stripping of the immunoblots after antibody incubation,
immunoprecipitates were split into equivalent aliquots after boiling
in sample buffer and analyzed by 10% SDS-PAGE. Detection of the
co-immunoprecipitated proteins was performed using the mono-
clonal antibodies anti-HA (clone 16B12; Covance Research Products,
http://www.crpinc.com), anti-methyl-PP2A (clone 2A10; Upstate,http://
www.upstate.com), anti-RRD2 [13], and anti-TPD3 (raised against
residues 65–597, clone 5G2), and the rabbit polyclonal antibodies
anti-CDC55 [9], anti-PPE1 (raised against full-length PPE1), anti-
PPH21 [13], anti-TAP42 (raised against full-length TAP42), and anti-
TPD3 [9].
For the experiment in Figure 3B, peptide competition and re-
immunoprecipitation was carried out as follows: 200 optical density
at 600 nm (OD600) logarithmically growing yeast cells were used for
myc-RRD2 immunoprecipitation. Immunoprecipitates were washed
and eluted by two sequential incubations for 5 min at 30 8C in the
presence of 100 or 50 lg/ml (ﬁrst and second elution, respectively) of
the myc peptide (MEQKLISEEDL) in TBS buffer. The eluates were
pooled and used for the second immunoprecipitation, carried out in
the same way as before, except using anti-HA antibody cross-linked
to protein A sepharose beads.
Disruption of PPH21 complexes and isolation of the monomeric
catalytic subunit. Monomeric HA-PPH21 was isolated by immuno-
precipitation of yeast lysates, which had been treated with a basic pH
shift to disrupt protein complexes, followed by neutralization. The
lysates were generated as described before by [13] except that the
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basic pH shift (pH 11.5) was obtained by adding 6.25 llo f
triethylamine to 500 ll of yeast cell lysate. After 5 min incubation
at room temperature, the reaction was neutralized by adding 330 ll
of 0.1 N HCl and was used for immunoprecipitation experiments/
phosphatase assays as described in the next paragraph.
Protein phosphatase assays. Phosphatase activity of PPH21 and
PPH22 immunoprecipitates was assayed towards
32P-labeled phos-
phorylase a,
32P-labeled histone H1, and para-nitrophenyl phosphate
(pNPP; Sigma, http://www.sigmaaldrich.com). Details about
32P-
labeled phosphorylase a and
32P-labeled histone H1 preparation
were described previously (see [38]).
To determine the phosphatase catalytic activity of HA-PPH21 or
HA-PPH22 towards phosphorylase a, histone HI, or pNPP, the
equivalent of 50 OD600 logarithmically growing cells were used for
native whole-cell lysate preparation as previously described [13]. The
lysates were used for immunoprecipitation (1 h at 4 8C, under
rocking) with 40 ll of anti-HA (12CA5) antibody cross-linked to BSA-
coated protein A sepharose beads (1:1 suspension in PBS). For PPH21
endogenous activity (Figure S3), the lysate was incubated with 2 llo f
rabbit polyclonal anti-PPH21 serum (or preimmune serum for
control immunoprecipitation) for 30 min followed by another 30
min in the presence of 40 ll of BSA-coated protein A sepharose beads
(1:1 suspension in PBS) at 4 8C. The immunoprecipitates were washed
one time with yeast lysis buffer and three times with TBS. To test the
catalytic activity of PPH21/PPH22 complexes (or the monomeric C
subunit) towards
32P-phosphorylase a or pNPP, one fourth of the
immunoprecipitate (resuspended in 400 ll of TBS) was used for
activity determination. For
32P-histone HI activity analysis, 1/32 of the
immunoprecipitate was used. In addition, one fourth of each of the
immunoprecipitates was used to normalize the PPH21 amounts (see
below). Further steps were performed as previously reported in detail
for PP2A isolated from mammalian cells [38].
The unspeciﬁc activity (background) was determined by using a
wild-type strain containing an empty vector (or for endogenous
PPH21, a wild-type strain incubated with PPH21 preimmune serum)
and was subtracted from each point determination.
The assay values (average of at least three independent experi-
ments) are presented as a percentage of the wild-type strain activity,
which was set as 100%. For this, the values were normalized to the
amount of immunoprecipitated PPH21/PPH22 as determined by
immunoblot and densitometer analysis using the Personal Densi-
tometer SI (Molecular Dynamics [GE Healthcare], http://www.
gehealthcare.com/usen/index.html) or the Odyssey Infrared Imaging
System (LI-COR, http://www.licor.com). We included for the assay
calculations only quantiﬁcations that revealed levels of HA-PPH21/
PPH22 that did not differ by more than 5.5-fold from the wild-type
reference (only the immunoblots for Figure 4C were analyzed with
conventional HRP detection). Moreover, we repeated the quantiﬁca-
tion if C subunit levels differed more than 5.5-fold, as follows: the
remaining aliquots of the immunoprecipitates were reanalyzed after
adjustment based on the rough quantiﬁcation of the ﬁrst immunoblot
and analyzed by SDS-PAGE/immunoblot analysis as described above.
Statistical analysis. Data are presented as mean values 6 standard
deviation (SD), and were analyzed using the Student t-test. Differ-
ences with p-values less than 0.05 were considered statistically
signiﬁcant.
Supporting Information
Figure S1. Loss of TPD3 Leads to a Decreased Serine/Threonine
Phosphatase Activity and Altered Substrate Speciﬁcity of the PP2A C
Subunit PPH22
(A) The catalytic activity of anti-HA immunoprecipitates from lysates
of wild-type (wt), tpd3D, rrd1D/rrd2D, and cdc55D/rts1D cells expressing
HA-tagged PPH22 was analyzed by phosphatase assays towards
phosphorylase a (n ¼ 4) or (B) para-nitrophenyl phosphate, pNPP (n
¼ 4).
Found at doi:10.1371/journal.pbio.0050155.sg001 (85 KB PDF).
Figure S2. The PP2A Serine/Threonine Phosphatase Activity in the
Absence of TPD3 or RRD1/2 Is Decreased Independently of the
Substrate Concentration
The catalytic activity of HA-PPH21 immunoprecipitates from lysates
of wild-type (wt), tpd3D, rrd1D/rrd2D, and cdc55D/rts1D cells expressing
HA-tagged PPH21 was analyzed by phosphatase assays towards
phosphorylase a (n ¼ 4). The catalytic activity was determined for
each strain by using three different substrate concentrations of
phosphorylase a (1, 10, and 100 lM).
Found at doi:10.1371/journal.pbio.0050155.sg002 (105 KB PDF).
Figure S3. The Serine/Threonine Phosphatase Activity of Endogenous
PPH21 Is Decreased in the Absence of TPD3
(A) Endogenous PPH21 was immunoprecipitated from wild-type (wt)
and tpd3D strains with a PPH21 polyclonal antibody, and analyzed by
SDS-PAGE and immunoblotting against PPH21 and RRD2. Preim-
mune serum was used for the control immunoprecipitation.
(B) An aliquot of the immunoprecipitates was tested for phosphatase
activity towards phosphorylase a (n ¼ 4). The asterisk indicates the
heavy chain of the anti-PPH21 antibody and other antibodies present
in the rabbit serum.
Found at doi:10.1371/journal.pbio.0050155.sg003 (163 KB PDF).
Table 2. Yeast Constructs
Constructs Characteristics/Expression Product Source
pYX142 CEN LEU2 TPI promoter R&D Systems
a
pYX142[HA-PPH21] N-terminal HA-tagged PPH21 [13]
pYES2 URA3 2l ori GAL1 promoter Invitrogen
pYES2[myc-PPE1] N-terminal myc-tagged PPE1 This study
pYES2[myc-RRD2] N-terminal myc-tagged RRD2 This study
ahttp://www.rndsystems.com
doi:10.1371/journal.pbio.0050155.t002
Table 1. Yeast Strains
Strains Genotypes Source
BY4741 MATa; his3D1; leu2D0; met15D0; ura3D0 Euroscarf
cdc55D/rts1D MATa; his3D1; leu2D0; met15D0; ura3D0; YGL190c::HIS3MX6; YOR014w::kanMX4 This study
ppe1D MATa; his3D1; leu2D0; met15D0; ura3D0; YHR075c::HIS3MX6 This study
ppm1D MATa; his3D1; leu2D0; met15D0; ura3D0; YDR435c::kanMX4 Euroscarf
rrd1D/rrd2D MATa; his3D1; leu2D0; met15D0; ura3D0; YIL153w::HIS3MX6; YPL152w::kanMX4 [13]
rrd1D/rrd2D/ppe1D MATa; his3D1; leu2D0; lys2D0; ura3D0; YHR075c::kanMX4; YIL153w::HIS3MX6;
YPL152w::kanMX4
This study
tpd3D MATa; his3D1; leu2D0; met15D0; ura3D0; YAL016w::kanMX4 Euroscarf
tpd3D/ppe1D MATa; his3D1; leu2D0; met15D0; ura3D0; YAL016w::kanMX4; YHR075c::HIS3MX6 This study
tpd3D/ppe1D/ppm1D MATa; his3D1; leu2D0; met15D0; ura3D0; YAL016w::kanMX4; YHR075c::HIS3MX6;
YDR435c::kanMX4
This study
All of the strains are descendant of the S288C background.
doi:10.1371/journal.pbio.0050155.t001
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PP2A Activity and Holoenzyme AssemblyFigure S4. A Basic pH Shift Promotes Dissociation of PP2A
Complexes
Untreated cell lysates (untreated/control) and cell lysates after a basic
pH shift/neutralization step (treated) from a HA-PPH21–expressing
wild-type (wt) (upper two panels) or tpd3D strain (lower two panels)
were analyzed by 5%–10% sucrose gradient sedimentation (Beckman
XL-90, rotor Sw60Ti, 4 h at 54,000 rpm, 4 8C). Twenty-ﬁve consecutive
fractions were collected (from the top to the bottom) and analyzed by
SDS-PAGE and immunoblotting. The sucrose gradient fractions
containing the sedimentation markers carbonic anhydrase (29 kDa),
albumin (66 kDa), aldolase (158 kDa), and catalase (232 kDa) are
indicated on the top with arrows. The membranes were incubated
with an anti-HA antibody.
Found at doi:10.1371/journal.pbio.0050155.sg004 (2.9 MB PDF).
Figure S5. The Serine/Threonine Phosphatase Activity of the
Monomeric C Subunit Isolated from a tpd3D or rrd1D/rrd2D Strain
Is Decreased Independently of the Substrate Concentration
Monomeric HA-PPH21 was immunoprecipitated from lysates of wild-
type (wt), tpd3D, rrd1D/rrd2D, and cdc55D/rts1D cells that were treated
with a basic pH shift to disrupt protein complexes followed by a
neutralization step (see Materials and Methods for details). The
serine/threonine phosphatase activity of the HA-tag immunopreci-
pitates was tested towards three different concentrations of
phosphorylase a (1, 10, and 100 lM) (n ¼ 3).
Found at doi:10.1371/journal.pbio.0050155.sg005 (108 KB PDF).
Acknowledgments
We thank David Brautigan, Helene Klug, Patrick Piribauer, Verle de
Weever, Christoph Schu ¨ller, and Karl Kuchler for materials and
advice. We are grateful to Patrick Hogan, Anjana Rao, Stefan
Schu ¨chner, and David Virshup for critical reading of the manuscript.
Author contributions. HH, DW, and EO conceived and designed
the experiments. HH, DW, IM, and CS performed the experiments.
HH, DW, IM, CS, and EO analyzed the data. TF and DHL contributed
reagents/materials/analysis tools. HH and EO wrote the paper.
Funding. This work was supported by grants from the Austrian
Science Foundation (FWF P15685), from the European Community
(STREP 512077), and from the Herzfelder Familienstiftung.
Competing interests. E g o nO g r i ss e r v e sa sac o n s u l t a n tt o
Millipore/Upstate Corporation.
References
1. Alonso A, Sasin J, Bottini N, Friedberg I, Osterman A, et al. (2004) Protein
tyrosine phosphatases in the human genome. Cell 117: 699–711.
2. Virshup DM (2000) Protein phosphatase 2A: A panoply of enzymes. Curr
Opin Cell Biol 12: 180–185.
3. Li X, Scuderi A, Letsou A, Virshup DM (2002) B56-associated protein
phosphatase 2A is required for survival and protects from apoptosis in
Drosophila melanogaster. Mol Cell Biol 22: 3674–3684.
4. Silverstein AM, Barrow CA, Davis AJ, Mumby MC (2002) Actions of PP2A
on the MAP kinase pathway and apoptosis are mediated by distinct
regulatory subunits. Proc Natl Acad Sci U S A 99: 4221–4226.
5. Tung HY, Alemany S, Cohen P (1985) The protein phosphatases involved in
cellular regulation. 2. Puriﬁcation, subunit structure and properties of
protein phosphatases-2A0, 2A1, and 2A2 from rabbit skeletal muscle. Eur J
Biochem 148: 253–263.
6. Mumby MC, Green DD, Russell KL (1985) Structural characterization of
cardiac protein phosphatase with a monoclonal antibody. Evidence that the
Mr ¼ 38,000 phosphatase is the catalytic subunit of the native enzyme(s). J
Biol Chem 260: 13763–13770.
7. Usui H, Imazu M, Maeta K, Tsukamoto H, Azuma K, et al. (1988) Three
distinct forms of type 2A protein phosphatase in human erythrocyte
cytosol. J Biol Chem 263: 3752–3761.
8. Baharians Z, Schonthal AH (1998) Autoregulation of protein phosphatase
type 2A expression. J Biol Chem 273: 19019–19024.
9. Wei H, Ashby DG, Moreno CS, Ogris E, Yeong FM, et al. (2001)
Carboxymethylation of the PP2A catalytic subunit in Saccharomyces cerevisiae
is required for efﬁcient interaction with the B-type subunits Cdc55p and
Rts1p. J Biol Chem 276: 1570–1577.
10. Wu J, Tolstykh T, Lee J, Boyd K, Stock JB, et al. (2000) Carboxyl methylation
of the phosphoprotein phosphatase 2A catalytic subunit promotes its
functional association with regulatory subunits in vivo. EMBO J 19: 5672–
5681.
11. Cho US, Xu W (2007) Crystal structure of a protein phosphatase 2A
heterotrimeric holoenzyme. Nature 445: 53–57.
12. Xu Y, Xing Y, Chen Y, Chao Y, Lin Z, et al. (2006) Structure of the protein
phosphatase 2A holoenzyme. Cell 127: 1239–1251.
13. Fellner T, Lackner DH, Hombauer H, Piribauer P, Mudrak I, et al. (2003) A
novel and essential mechanism determining speciﬁcity and activity of
protein phosphatase 2A (PP2A) in vivo. Genes Dev 17: 2138–2150.
14. van Zyl W, Huang W, Sneddon AA, Stark M, Camier S, et al. (1992)
Inactivation of the protein phosphatase 2A regulatory subunit A results in
morphological and transcriptional defects in Saccharomyces cerevisiae. Mol
Cell Biol 12: 4946–4959.
15. Ronne H, Carlberg M, Hu GZ, Nehlin JO (1991) Protein phosphatase 2A in
Saccharomyces cerevisiae: Effects on cell growth and bud morphogenesis. Mol
Cell Biol 11: 4876–4884.
16. Tonks NK, Cohen P (1984) The protein phosphatases involved in cellular
regulation. Identiﬁcation of the inhibitor-2 phosphatases in rabbit skeletal
muscle. Eur J Biochem 145: 65–70.
17. Di Como CJ, Arndt KT (1996) Nutrients, via the Tor proteins, stimulate the
association of Tap42 with type 2A phosphatases. Genes Dev 10: 1904–1916.
18. Jiang Y, Broach JR (1999) Tor proteins and protein phosphatase 2A
reciprocally regulate Tap42 in controlling cell growth in yeast. EMBO J 18:
2782–2792.
19. Schmelzle T, Hall MN (2000) TOR, a central controller of cell growth. Cell
103: 253–262.
20. Zheng Y, Jiang Y (2005) The yeast phosphotyrosyl phosphatase activator is
part of the Tap42-phosphatase complexes. Mol Biol Cell 16: 2119–2127.
21. Sola MM, Langan T, Cohen P (1991) p34cdc2 phosphorylation sites in
histone H1 are dephosphorylated by protein phosphatase 2a1. Biochim
Biophys Acta 1094: 211–216.
22. Cegielska A, Shaffer S, Derua R, Goris J, Virshup DM (1994) Different
oligomeric forms of protein phosphatase 2A activate and inhibit simian
virus 40 DNA replication. Mol Cell Biol 14: 4616–4623.
23. Tolstykh T, Lee J, Vafai S, Stock JB (2000) Carboxyl methylation regulates
phosphoprotein phosphatase 2A by controlling the association of
regulatory B subunits. EMBO J 19: 5682–5691.
24. Longin S, Jordens J, Martens E, Stevens I, Janssens V, et al. (2004) An
inactive protein phosphatase 2A population is associated with methyl-
esterase and can be re-activated by the phosphotyrosyl phosphatase
activator. Biochem J 380: 111–119.
25. Ogris E, Du X, Nelson KC, Mak EK, Yu XX, et al. (1999) A protein
phosphatase methylesterase (PME-1) is one of several novel proteins stably
associating with two inactive mutants of protein phosphatase 2A. J Biol
Chem 274: 14382–14391.
26. Wang H, Jiang Y (2003) The Tap42-protein phosphatase type 2A catalytic
subunit complex is required for cell cycle-dependent distribution of actin
in yeast. Mol Cell Biol 23: 3116–3125.
27. Van Hoof C, Martens E, Longin S, Jordens J, Stevens I, et al. (2005) Speciﬁc
interactions of PP2A and PP2A-like phosphatases with the yeast PTPA
homologues, Ypa1 and Ypa2. Biochem J 386: 93–102.
28. Jordens J, Janssens V, Longin S, Stevens I, Martens E, et al. (2006) The
protein phosphatase 2A phosphatase activator is a novel peptidyl-prolyl cis/
trans-isomerase. J Biol Chem 281: 6349–6357.
29. Leulliot N, Vicentini G, Jordens J, Quevillon-Cheruel S, Schiltz M, et al.
(2006) Crystal structure of the PP2A phosphatase activator: implications for
its PP2A-speciﬁc PPIase activity. Mol Cell 23: 413–424.
30. Magnusdottir A, Stenmark P, Flodin S, Nyman T, Hammarstrom M, et al.
(2006) The crystal structure of a human PP2A phosphatase activator reveals
a novel fold and highly conserved cleft implicated in protein-protein
interactions. J Biol Chem 281: 22434–22438.
31. Krogan NJ, Cagney G, Yu H, Zhong G, Guo X, et al. (2006) Global landscape
of protein complexes in the yeast Saccharomyces cerevisiae. Nature 440: 637–
643.
32. Chao Y, Xing Y, Chen Y, Xu Y, Lin Z, et al. (2006) Structure and mechanism
of the phosphotyrosyl phosphatase activator. Mol Cell 23: 535–546.
33. Huang FL, Glinsmann WH (1976) Separation and characterization of two
phosphorylase phosphatase inhibitors from rabbit skeletal muscle. Eur J
Biochem 70: 419–426.
34. Tung HY, Wang W, Chan CS (1995) Regulation of chromosome segregation
by Glc8p, a structural homolog of mammalian inhibitor 2 that functions as
both an activator and an inhibitor of yeast protein phosphatase 1. Mol Cell
Biol 15: 6064–6074.
35. Hemmings BA, Resink TJ, Cohen P (1982) Reconstitution of a Mg-ATP-
dependent protein phosphatase and its activation through a phosphor-
ylation mechanism. FEBS Lett 150: 319–324.
36. MacKintosh C, Garton AJ, McDonnell A, Barford D, Cohen PT, et al. (1996)
Further evidence that inhibitor-2 acts like a chaperone to fold PP1 into its
native conformation. FEBS Lett 397: 235–238.
37. Wach A, Brachat A, Alberti-Segui C, Rebischung C, Philippsen P (1997)
Heterologous HIS3 marker and GFP reporter modules for PCR-targeting
in Saccharomyces cerevisiae. Yeast 13: 1065–1075.
38. Fellner T, Piribauer P, Ogris E (2003) Altering the holoenzyme composition
and substrate speciﬁcity of protein phosphatase 2A. Methods Enzymol 366:
187–203.
PLoS Biology | www.plosbiology.org June 2007 | Volume 5 | Issue 6 | e155 1365
PP2A Activity and Holoenzyme Assembly